news Novo Nordisk partners with OpenAI as AI drug discovery hopes mount By AdminApril 14, 2026Less 1 min read2 Views0 The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs. ShareTweetPinShare Previous PostAsia markets mostly higher amid hopes of a U.S.-Iran deal; China exports miss estimates Next PostEuropean markets rise on hopes that Iran peace talks can resume Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like March 6, 20260 Comments Iran’s Shahed drone: How ‘the poor man’s cruise missile’ is shaping Tehran’s retaliation February 6, 20260 Comments New Jersey House Primary Remains Too Close to Call January 16, 20260 Comments Virginia lawmakers pass redistricting amendment, sending it to voters for approval December 23, 20250 Comments Russell Brand Is Charged With Additional Counts of Rape and Sexual Assault
March 6, 20260 Comments Iran’s Shahed drone: How ‘the poor man’s cruise missile’ is shaping Tehran’s retaliation
January 16, 20260 Comments Virginia lawmakers pass redistricting amendment, sending it to voters for approval
December 23, 20250 Comments Russell Brand Is Charged With Additional Counts of Rape and Sexual Assault